{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-021504","form_type":"8-K","ticker":"PMI","cik":"0002030617","company_name":"Picard Medical, Inc.","filed_at":"2026-06-24T11:45:56+00:00","discovered_at":"2026-06-24T11:50:00.251294+00:00","generated_at":"2026-06-24T11:50:10.999583+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Picard Medical CEO Patrick Schnegelsberg steps down; Chairman Richard Fang named interim CEO","bullets":["Patrick NJ Schnegelsberg resigned as CEO and board member effective June 18, 2026; departure not related to any disagreement.","Board appointed Richard Fang, Ph.D., current Chairman, as Interim CEO effective June 18, 2026; he will serve until permanent successor found.","Dr. Fang previously served as CEO from 2021 to 2023; founded Reach Surgical and has over 20 years med-tech experience.","As Interim CEO, Dr. Fang will receive an annual salary of $400,000."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-021504","json":"https://secwatch.observer/filing/0001437749-26-021504.json","markdown":"https://secwatch.observer/filing/0001437749-26-021504.md","text":"https://secwatch.observer/filing/0001437749-26-021504.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926021504/0001437749-26-021504-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926021504/pmi20260618_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T11:50:10.999583+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5f7e5b0d32","claim":"Richard Fang was appointed as Interim Chief Executive Officer at Picard Medical, Inc..","evidence_excerpt":"The Board appointed Richard Fang, Ph.D., 60, as the Company's Interim Chief Executive Officer, effective as of the Separation Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926021504/0001437749-26-021504-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"b517480e84","claim":"Patrick NJ Schnegelsberg resigned as Chief Executive Officer and Director at Picard Medical, Inc..","evidence_excerpt":"On June 17, 2026, Patrick NJ Schnegelsberg notified Picard Medical, Inc. (the \"Company\") of his decision to step down as Chief Executive Officer and as a member of the Board of Directors of the Company (the \"Board\"), effective June 18, 2026","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2030617/000143774926021504/0001437749-26-021504-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Executive Officer and Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}